New research compares corticosteroid dosing regimens for DMD
Intermittent prednisone increased the risk of cushingoid appearance, excess hair growth and high blood pressure in patients with DMD.
News
-
-
How virtual reality may change DMD rehabilitation treatment
Virtual reality (VR) is becoming a promising tool in the rehab toolbox for people with Duchenne muscular dystrophy (DMD).
-
Review identifies what physical activity really means to people with DMD
For people with DMD, physical activity is about more than walking, with independence and quality of life tied to meaningful movement.
-
Scoliosis-correcting surgery could improve survival in DMD
Scoliosis-correcting surgery may prolong survival in patients with Duchenne muscular dystrophy (DMD), according to study.
-
New research identifies inhibiting EZH2 as potential DMD treatment
A new study found that blocking the protein EZH2 with an inhibitor drug improved muscle health and function in mice with DMD.
-
New genetic therapy shows promise in improving muscle health in DMD
A new genetic therapy, WVE-N531, has shown promise in improving muscle health in boys with Duchenne muscular dystrophy (DMD).
-
Study finds no clear benefit in heart function from starting cardiac drugs early in DMD
Starting heart medications early in boys with Duchenne muscular dystrophy (DMD) did not prevent the heart’s decline over five years.
-
Case study examines nighttime ventilation in patients with both DMD and autism
A recent case study shows the challenges of initiating non-invasive ventilation (NIV) in patients with DMD and neurocognitive comorbidities.
-
DMD progression found to vary greatly among patients
In Duchenne muscular dystrophy (DMD), the age when symptoms start and how quickly they get worse can be very different from person to person.
-
Children with DMD face challenges performing two tasks at once, study finds
Boys with DMD have a harder time doing two things at once than their peers without the disease, negatively affecting everyday life.
